Literature DB >> 25015657

MDR1 transporter protects against paraquat-induced toxicity in human and mouse proximal tubule cells.

Xia Wen1, Christopher J Gibson2, Ill Yang3, Brian Buckley3, Michael J Goedken4, Jason R Richardson5, Lauren M Aleksunes6.   

Abstract

Paraquat is a herbicide that is highly toxic to the lungs and kidneys following acute exposures. Prior studies have demonstrated that the organic cation transporter 2 and multidrug and toxin extrusion protein 1 contribute to the urinary secretion of paraquat in the kidneys. The purpose of this study was to determine whether the multidrug resistance protein 1 (MDR1/Mdr1, ABCB1, or P-glycoprotein) also participates in the removal of paraquat from the kidneys and protects against renal injury. Paraquat transport and toxicity were quantified in human renal proximal tubule epithelial cells (RPTEC) that endogenously express MDR1, HEK293 cells overexpressing MDR1, and Mdr1a/1b knockout mice. In RPTEC cells, reduction of MDR1 activity using the antagonist PSC833 or siRNA transfection increased the cellular accumulation of paraquat by 50%. Reduced efflux of paraquat corresponded with enhanced cytotoxicity in PSC833-treated cells. Likewise, stable overexpression of the human MDR1 gene in HEK293 cells reduced intracellular levels of paraquat by 50%. In vivo studies assessed the renal accumulation and subsequent nephrotoxicity of paraquat (10 or 30 mg/kg ip) in wild-type and Mdr1a/1b knockout mice. At 4 h after paraquat treatment, renal concentrations of paraquat in the kidneys of Mdr1a/1b knockout mice were 750% higher than wild-type mice. By 72 h, paraquat-treated Mdr1a/1b knockout mice had more extensive tubular degeneration and significantly greater mRNA expression of kidney injury-responsive genes, including kidney injury molecule-1, lipocalin-2, and NAD(P)H quinone oxidoreductase 1, compared with wild-type mice. In conclusion, MDR1/Mdr1 participates in the elimination of paraquat from the kidneys and protects against subsequent toxicity.
© The Author 2014. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  ABCB1; MDR1; Mdr1a; P-glycoprotein; paraquat; proximal tubule

Mesh:

Substances:

Year:  2014        PMID: 25015657      PMCID: PMC4271045          DOI: 10.1093/toxsci/kfu141

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  20 in total

1.  Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids.

Authors:  Doaa M Youssef; Tarek A Attia; Amal S El-Shal; Fawzya A Abduelometty
Journal:  Gene       Date:  2013-08-27       Impact factor: 3.688

2.  Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine.

Authors:  N Viñolas; M Provencio; N Reguart; F Cardenal; V Alberola; J M Sánchez-Torres; F J Barón; M Cobo; I Maestu; I Moreno; C Mesía; A Izquierdo; E Felip; M López-Brea; A Márquez; M Sánchez-Ronco; M Tarón; M C Santarpia; R Rosell
Journal:  Lung Cancer       Date:  2011-02       Impact factor: 5.705

3.  Inhibition of human MDR1 and BCRP transporter ATPase activity by organochlorine and pyrethroid insecticides.

Authors:  Kristin M Bircsak; Jason R Richardson; Lauren M Aleksunes
Journal:  J Biochem Mol Toxicol       Date:  2012-11-20       Impact factor: 3.642

Review 4.  Medical management of paraquat ingestion.

Authors:  Indika B Gawarammana; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

5.  The toxicity of paraquat.

Authors:  D G Clark; T F McElligott; E W Hurst
Journal:  Br J Ind Med       Date:  1966-04

6.  MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-small-cell lung cancer.

Authors:  Ji-Hong Pan; Jin-Xiang Han; Jian-Mei Wu; Hai-Nan Huang; Qing-Zhong Yu; Li-Jun Sheng
Journal:  Respiration       Date:  2008-09-24       Impact factor: 3.580

7.  Absence of P-glycoprotein transport in the pharmacokinetics and toxicity of the herbicide paraquat.

Authors:  Sarah E Lacher; Julia N Gremaud; Kasse Skagen; Emily Steed; Rachel Dalton; Kent D Sugden; Fernando Cardozo-Pelaez; Catherine M T Sherwin; Erica L Woodahl
Journal:  J Pharmacol Exp Ther       Date:  2013-12-02       Impact factor: 4.030

8.  Quantification of Paraquat, MPTP, and MPP+ in brain tissue using microwave-assisted solvent extraction (MASE) and high-performance liquid chromatography-mass spectrometry.

Authors:  Bozena Winnik; Dana B Barr; Mona Thiruchelvam; M Angela Montesano; Eric K Richfield; Brian Buckley
Journal:  Anal Bioanal Chem       Date:  2009-07-19       Impact factor: 4.142

9.  Inflammatory regulation of ATP binding cassette efflux transporter expression and function in microglia.

Authors:  Christopher J Gibson; Muhammad M Hossain; Jason R Richardson; Lauren M Aleksunes
Journal:  J Pharmacol Exp Ther       Date:  2012-08-31       Impact factor: 4.030

10.  Deficiency of multidrug and toxin extrusion 1 enhances renal accumulation of paraquat and deteriorates kidney injury in mice.

Authors:  Qing Li; Xiujuan Peng; Hyekyung Yang; Hongbing Wang; Yan Shu
Journal:  Mol Pharm       Date:  2011-10-12       Impact factor: 4.939

View more
  14 in total

1.  Placental BCRP/ABCG2 Transporter Prevents Fetal Exposure to the Estrogenic Mycotoxin Zearalenone.

Authors:  John T Szilagyi; Ludwik Gorczyca; Anita Brinker; Brian Buckley; Jeffrey D Laskin; Lauren M Aleksunes
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

Review 2.  Advances in predictive in vitro models of drug-induced nephrotoxicity.

Authors:  Joanne Y-C Soo; Jitske Jansen; Rosalinde Masereeuw; Melissa H Little
Journal:  Nat Rev Nephrol       Date:  2018-06       Impact factor: 28.314

Review 3.  Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Authors:  Sascha C T Nicklisch; Amro Hamdoun
Journal:  FEBS Lett       Date:  2020-12-09       Impact factor: 4.124

4.  Intravenous injection of Xuebijing attenuates acute kidney injury in rats with paraquat intoxication.

Authors:  Jia-Jun Xu; Jian-Tao Zhen; Li Tang; Qing-Ming Lin
Journal:  World J Emerg Med       Date:  2017

Review 5.  Xenobiotic transporters and kidney injury.

Authors:  Blessy George; Dahea You; Melanie S Joy; Lauren M Aleksunes
Journal:  Adv Drug Deliv Rev       Date:  2017-01-20       Impact factor: 15.470

Review 6.  Understanding paraquat resistance mechanisms in Arabidopsis thaliana to facilitate the development of paraquat-resistant crops.

Authors:  Tahmina Nazish; Yi-Jie Huang; Jing Zhang; Jin-Qiu Xia; Alamin Alfatih; Chao Luo; Xiao-Teng Cai; Jing Xi; Ping Xu; Cheng-Bin Xiang
Journal:  Plant Commun       Date:  2022-03-25

7.  Nrf2 Regulates the Sensitivity of Mouse Keratinocytes to Nitrogen Mustard via Multidrug Resistance-Associated Protein 1 (Mrp1).

Authors:  Ronald G Udasin; Xia Wen; Kristin M Bircsak; Lauren M Aleksunes; Michael P Shakarjian; Ah-Ng Tony Kong; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2015-10-09       Impact factor: 4.849

8.  Sequential organ failure assessment in predicting mortality after paraquat poisoning: A meta-analysis.

Authors:  Wen Jie Wang; Li Wei Zhang; Shun Yi Feng; Jie Gao; Yong Li
Journal:  PLoS One       Date:  2018-11-16       Impact factor: 3.240

9.  Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation.

Authors:  Mark Borris D Aldonza; Ji-Young Hong; Malona V Alinsug; Jayoung Song; Sang Kook Lee
Journal:  Oncotarget       Date:  2016-06-07

10.  Effect of MDR1 gene polymorphisms on mortality in paraquat intoxicated patients.

Authors:  Hak Jae Kim; Hyung-Ki Kim; Jun-Tack Kwon; Sun-Hyo Lee; Sam El Park; Hyo-Wook Gil; Ho-Yeon Song; Sae-Yong Hong
Journal:  Sci Rep       Date:  2016-08-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.